US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 0.690
  • -0.010-1.40%
Close Apr 26 16:00 ET
  • 0.710
  • +0.020+2.90%
Post 18:51 ET
82.36MMarket Cap-264P/E (TTM)

Atara Biotherapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-86.51%8.57M
1,823.98%4.25M
-52.05%2.14M
-98.14%957K
-83.24%1.23M
212.55%63.57M
-97.07%221K
-16.96%4.46M
1,232.79%51.58M
105.91%7.31M
Operating revenue
-86.51%8.57M
1,823.98%4.25M
-52.05%2.14M
-98.14%957K
-83.24%1.23M
212.55%63.57M
-97.07%221K
-16.96%4.46M
1,232.79%51.58M
105.91%7.31M
Cost of revenue
8.89M
3.16M
2.62M
2.9M
216K
0
0
0
0
0
Gross profit
-100.49%-313K
394.12%1.09M
-110.70%-477K
-103.76%-1.94M
-86.19%1.01M
63.57M
221K
4.46M
51.58M
7.31M
Operating expense
-19.88%275.69M
-19.41%61.05M
-22.39%69.14M
-17.00%69.48M
-20.42%76.03M
-4.63%344.09M
-24.95%75.76M
-1.22%89.08M
-4.74%83.71M
16.79%95.53M
Selling and administrative expenses
-28.85%50.91M
-13.52%11.45M
-35.28%12.25M
-29.12%13.34M
-32.57%13.87M
-9.20%71.55M
-39.29%13.25M
-4.66%18.92M
-3.01%18.81M
15.97%20.57M
-General and administrative expense
-28.85%50.91M
-13.52%11.45M
-35.28%12.25M
-29.12%13.34M
-32.57%13.87M
-9.20%71.55M
-39.29%13.25M
-4.66%18.92M
-3.01%18.81M
15.97%20.57M
Research and development costs
-17.52%224.79M
-20.66%49.6M
-18.91%56.89M
-13.49%56.14M
-17.08%62.16M
-3.36%272.53M
-21.00%62.52M
-0.25%70.16M
-5.22%64.9M
17.02%74.96M
Operating profit
1.61%-276.01M
20.62%-59.96M
17.74%-69.61M
-122.25%-71.41M
14.96%-75.02M
17.61%-280.51M
19.13%-75.54M
0.22%-84.62M
61.75%-32.13M
-12.75%-88.22M
Net non-operating interest income expense
-94.75%141K
-144.80%-465K
-120.82%-177K
-44.87%317K
108.04%466K
631.88%2.69M
1,135.71%1.04M
474.32%850K
155.56%575K
348.89%224K
Non-operating interest income
77.38%5.43M
-38.44%711K
25.18%1.22M
140.77%1.7M
690.35%1.8M
733.51%3.06M
--1.16M
--973K
--704K
--228K
Non-operating interest expense
1,316.89%5.29M
905.13%1.18M
1,034.15%1.4M
968.22%1.38M
33,300.00%1.34M
--373K
--117K
--123K
--129K
--4K
Other net income (expense)
-100.50%-246K
82.61%-12K
91.26%-27K
-100.02%-10K
-80.73%-197K
49.54M
-69K
-309K
50.02M
-109K
Special income (charges)
--0
--0
--0
--0
----
--50.24M
--0
--0
--50.24M
----
-Gain on sale of business
----
----
----
--0
----
----
----
----
--50.24M
----
-Gain on sale of property,plant,equipment
--0
--0
--0
----
----
--50.24M
--0
--0
----
----
Other non- operating income (expenses)
64.86%-246K
82.61%-12K
91.26%-27K
95.33%-10K
-80.73%-197K
---700K
---69K
---309K
---214K
---109K
Income before tax
-20.95%-276.11M
18.95%-60.44M
16.97%-69.82M
-485.07%-71.11M
15.16%-74.75M
32.87%-228.29M
20.09%-74.57M
0.69%-84.08M
122.04%18.47M
-12.47%-88.11M
Income tax
25.00%15K
450.00%11K
-290.00%-19K
1K
22K
-73.91%12K
-93.33%2K
10K
0
0
Net income
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
Net income continuous Operations
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
Minority interest income
Net income attributable to the parent company
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
0.68%-84.09M
122.04%18.47M
-12.47%-88.11M
Basic earnings per share
-16.52%-2.61
22.22%-0.56
19.51%-0.66
-477.78%-0.68
17.24%-0.72
38.29%-2.24
25.00%-0.72
8.89%-0.82
119.78%0.18
-1.16%-0.87
Diluted earnings per share
-16.52%-2.61
22.22%-0.56
19.51%-0.66
-477.78%-0.68
17.24%-0.72
38.29%-2.24
25.00%-0.72
8.89%-0.82
119.78%0.18
-1.16%-0.87
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -86.51%8.57M1,823.98%4.25M-52.05%2.14M-98.14%957K-83.24%1.23M212.55%63.57M-97.07%221K-16.96%4.46M1,232.79%51.58M105.91%7.31M
Operating revenue -86.51%8.57M1,823.98%4.25M-52.05%2.14M-98.14%957K-83.24%1.23M212.55%63.57M-97.07%221K-16.96%4.46M1,232.79%51.58M105.91%7.31M
Cost of revenue 8.89M3.16M2.62M2.9M216K00000
Gross profit -100.49%-313K394.12%1.09M-110.70%-477K-103.76%-1.94M-86.19%1.01M63.57M221K4.46M51.58M7.31M
Operating expense -19.88%275.69M-19.41%61.05M-22.39%69.14M-17.00%69.48M-20.42%76.03M-4.63%344.09M-24.95%75.76M-1.22%89.08M-4.74%83.71M16.79%95.53M
Selling and administrative expenses -28.85%50.91M-13.52%11.45M-35.28%12.25M-29.12%13.34M-32.57%13.87M-9.20%71.55M-39.29%13.25M-4.66%18.92M-3.01%18.81M15.97%20.57M
-General and administrative expense -28.85%50.91M-13.52%11.45M-35.28%12.25M-29.12%13.34M-32.57%13.87M-9.20%71.55M-39.29%13.25M-4.66%18.92M-3.01%18.81M15.97%20.57M
Research and development costs -17.52%224.79M-20.66%49.6M-18.91%56.89M-13.49%56.14M-17.08%62.16M-3.36%272.53M-21.00%62.52M-0.25%70.16M-5.22%64.9M17.02%74.96M
Operating profit 1.61%-276.01M20.62%-59.96M17.74%-69.61M-122.25%-71.41M14.96%-75.02M17.61%-280.51M19.13%-75.54M0.22%-84.62M61.75%-32.13M-12.75%-88.22M
Net non-operating interest income expense -94.75%141K-144.80%-465K-120.82%-177K-44.87%317K108.04%466K631.88%2.69M1,135.71%1.04M474.32%850K155.56%575K348.89%224K
Non-operating interest income 77.38%5.43M-38.44%711K25.18%1.22M140.77%1.7M690.35%1.8M733.51%3.06M--1.16M--973K--704K--228K
Non-operating interest expense 1,316.89%5.29M905.13%1.18M1,034.15%1.4M968.22%1.38M33,300.00%1.34M--373K--117K--123K--129K--4K
Other net income (expense) -100.50%-246K82.61%-12K91.26%-27K-100.02%-10K-80.73%-197K49.54M-69K-309K50.02M-109K
Special income (charges) --0--0--0--0------50.24M--0--0--50.24M----
-Gain on sale of business --------------0------------------50.24M----
-Gain on sale of property,plant,equipment --0--0--0----------50.24M--0--0--------
Other non- operating income (expenses) 64.86%-246K82.61%-12K91.26%-27K95.33%-10K-80.73%-197K---700K---69K---309K---214K---109K
Income before tax -20.95%-276.11M18.95%-60.44M16.97%-69.82M-485.07%-71.11M15.16%-74.75M32.87%-228.29M20.09%-74.57M0.69%-84.08M122.04%18.47M-12.47%-88.11M
Income tax 25.00%15K450.00%11K-290.00%-19K1K22K-73.91%12K-93.33%2K10K00
Net income -20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M0.68%-84.09M122.04%18.47M-12.47%-88.11M
Net income continuous Operations -20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M0.68%-84.09M122.04%18.47M-12.47%-88.11M
Minority interest income
Net income attributable to the parent company -20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M0.68%-84.09M122.04%18.47M-12.47%-88.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M0.68%-84.09M122.04%18.47M-12.47%-88.11M
Basic earnings per share -16.52%-2.6122.22%-0.5619.51%-0.66-477.78%-0.6817.24%-0.7238.29%-2.2425.00%-0.728.89%-0.82119.78%0.18-1.16%-0.87
Diluted earnings per share -16.52%-2.6122.22%-0.5619.51%-0.66-477.78%-0.6817.24%-0.7238.29%-2.2425.00%-0.728.89%-0.82119.78%0.18-1.16%-0.87
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg